Oct 02, 2025 • Zacks Commentary
BULLISH
BLCO vs. DHR: Which Stock Should Value Investors Buy Now?
BLCO vs. DHR: Which Stock Is the Better Value Option?
Aug 29, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Bausch ( BHC ) Up 21.4% Since Last Earnings Report: Can It Continue?
Bausch (BHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Jul 31, 2025 • Zacks Commentary
NEUTRAL
Bausch Health Stock Falls on Q2 Earnings Miss, Revenues Beat
BHC stock falls 6.3% as Q2 earnings miss estimates despite stronger sales and growth in key segments like Salix and Solta Medical.
Jul 31, 2025 • Motley Fool
SOMEWHAT-BULLISH
Bausch Lomb ( BLCO ) Q2 Revenue Rises 5%
Bausch + Lomb ( NYSE:BLCO ) , a global eye health company known for its contact lenses, surgical devices, and eye pharmaceuticals, released results for the second quarter of fiscal 2025 on July 30, 2025. The main headline from the release is GAAP revenue growth of 5% year over year to $1.278 ...
Jul 30, 2025 • Zacks Commentary
NEUTRAL
Bausch + Lomb ( BLCO ) Q2 Earnings and Revenues Surpass Estimates
Bausch + Lomb (BLCO) delivered earnings and revenue surprises of +16.67% and +2.37%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?